Sensory–Motor Polyneuropathy in an 11-year- old Girl with a Pathogenic Variant in SMC1A: A Case Report

Abstract

Pathogenic variants in the SMC1A gene are often dominant-negative and cause an X-linked form of Cornelia de Lange syndrome (CdLS) with growth retardation and typical facial features. However, rare SMC1A variants cause a developmental and epileptic encephalopathy (DEE) with intractable early-onset epilepsy that is absent in CdLS. Here we describe an 11-year-old girl with epilepsy, walking disorder, and neurodevelopmental disorder. A neurophysiological examination of nerve conduction velocity showed a mixed, sensory–motor, chronic 4-limb polyneuropathy. Whole-exome sequencing identified the variant c.3145C > T p.(Arg1049*) in SMC1A (NM_006306.3), which can be classified as pathogenic. To the best of our knowledge, among 79 individuals with SMC1A-related DEE reported in the literature, altered peripheral nerve conduction has never been described. In this article, we propose that severe sensory–motor polyneuropathy could be an expansion of the SMC1A-related phenotype.

Keywords

SMC1A - epilepsy - neurodevelopmental disorder - neuropathy

Ethical Approval

The authors declare that this paper complies with internationally accepted standards for research practice and reporting. Written informed consent to participate and written consent to publish were obtained from the patient's parents for the publication of this report.

Authors' Contributions

Conceptualization C.A.C., C.F.; clinical data collection and data curation A.D.L., C.A.C., M.P., G.C., S.G.C., A.L., C.S., D.F., S.R., A.C., C.F.; writing—original draft preparation, A.D.L., C.A.C., M.P., S.G.C.; writing—review and editing, C.A.C., M.P., S.G.C., C.S.; supervision, L.G., C.F. All authors have read and agreed to the published version of the manuscript.

Availability of Data and Materials

The data used for this paper will be made available by the corresponding author upon reasonable request.

Publikationsverlauf

Eingereicht: 16. August 2024

Angenommen: 21. Oktober 2024

Artikel online veröffentlicht:
14. November 2024

• References

• 1 Jansen S, Kleefstra T, Willemsen MH. et al. De novo loss-of-function mutations in X-linked SMC1A cause severe ID and therapy-resistant epilepsy in females: expanding the phenotypic spectrum. Clin Genet 2016; 90 (05) 413-419
• 2 Symonds JD, Joss S, Metcalfe KA. et al; DDD Study. Heterozygous truncation mutations of the SMC1A gene cause a severe early onset epilepsy with cluster seizures in females: detailed phenotyping of 10 new cases. Epilepsia 2017; 58 (04) 565-575
• 3 Pié J, Gil-Rodríguez MC, Ciero M. et al. Mutations and variants in the cohesion factor genes NIPBL, SMC1A, and SMC3 in a cohort of 30 unrelated patients with Cornelia de Lange syndrome. Am J Med Genet A 2010; 152A [phone]
• 4 Gibellato E, Cianci P, Mariani M. et al. SMC1A epilepsy syndrome: clinical data from a large international cohort. Am J Med Genet A 2024; 194 (07) e63577
• 5 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 6 Turner TN, Wilfert AB, Bakken TE. et al. Sex-based analysis of de novo variants in neurodevelopmental disorders. Am J Hum Genet 2019; 105 (06) 1274-1285
• 7 Martin HC, Gardner EJ, Samocha KE. et al; Deciphering Developmental Disorders Study. The contribution of X-linked coding variation to severe developmental disorders. Nat Commun 2021; 12 (01) 627
• 8 Bozarth XL, Lopez J, Fang H, Lee-Eng J, Duan Z, Deng X. Phenotypes and genotypes in patients with SMC1A-related developmental and epileptic encephalopathy. Genes (Basel) 2023; 14 (04) 852
• 9 Kaur M, Blair J, Devkota B. et al. Genomic analyses in Cornelia de Lange syndrome and related diagnoses: novel candidate genes, genotype-phenotype correlations and common mechanisms. Am J Med Genet A 2023; 191 (08) 2113-2131
• 10 Huisman S, Mulder PA, Redeker E. et al. Phenotypes and genotypes in individuals with SMC1A variants. Am J Med Genet A 2017; 173 (08) 2108-2125
• 11 Yatskevich S, Rhodes J, Nasmyth K. Organization of chromosomal DNA by SMC complexes. Annu Rev Genet 2019; 53: 445-482
• 12 Musio A. The multiple facets of the SMC1A gene. Gene 2020; 743: 144612
• 13 Remeseiro S, Cuadrado A, Losada A. Cohesin in development and disease. Development 2013; 140 (18) 3715-3718
• 14 Soardi FC, Machado-Silva A, Linhares ND. et al. Familial STAG2 germline mutation defines a new human cohesinopathy. NPJ Genom Med 2017; 2: 7
• 15 Lebrun N, Lebon S, Jeannet PY, Jacquemont S, Billuart P, Bienvenu T. Early-onset encephalopathy with epilepsy associated with a novel splice site mutation in SMC1A. Am J Med Genet A 2015; 167A (12) 3076-3081
• 16 Goldstein JH, Tim-Aroon T, Shieh J. et al. Novel SMC1A frameshift mutations in children with developmental delay and epilepsy. Eur J Med Genet 2015; 58 (10) 562-568
• 17 Schuldiner O, Berdnik D, Levy JM. et al. piggyBac-based mosaic screen identifies a postmitotic function for cohesin in regulating developmental axon pruning. Dev Cell 2008; 14 (02) 227-238
• 18 Cheng N, Li G, Kanchwala M, Evers BM, Xing C, Yu H. STAG2 promotes the myelination transcriptional program in oligodendrocytes. eLife 2022; 11: e77848